Focusing on a 28-amino-acid segment, investigators generated more than 200,000 variants of the AAV2 wildtype sequence, which yielded some 110,000 viable engineered capsids, half of which surpassed the average diversity of natural AAV serotype sequences with 12-29 mutations across the region . . .

Get GEN Edge Today!

See More on the Edge

Continue reading this article and more
with a GEN Edge subscription

Start Your 30-Day Free Trial Now

Log In Join GEN Edge